Dimensional Fund Advisors LP Has $148.53 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Dimensional Fund Advisors LP trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 494,877 shares of the company's stock after selling 8,488 shares during the quarter. Dimensional Fund Advisors LP owned 0.20% of HCA Healthcare worth $148,529,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. Barclays PLC increased its stake in HCA Healthcare by 22.3% during the third quarter. Barclays PLC now owns 571,975 shares of the company's stock valued at $232,467,000 after acquiring an additional 104,409 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in HCA Healthcare during the third quarter worth $688,000. Franklin Resources Inc. lifted its holdings in shares of HCA Healthcare by 11.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company's stock worth $660,842,000 after acquiring an additional 174,946 shares during the period. American Trust bought a new stake in HCA Healthcare in the third quarter valued at about $372,000. Finally, Oddo BHF Asset Management Sas bought a new position in HCA Healthcare during the third quarter worth about $3,278,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently commented on HCA. Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Truist Financial reduced their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Guggenheim began coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $381.13.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Stock Up 1.4 %

HCA stock traded up $4.80 during mid-day trading on Wednesday, hitting $345.38. 1,330,377 shares of the company were exchanged, compared to its average volume of 1,397,627. The firm's 50 day simple moving average is $331.02 and its 200 day simple moving average is $331.49. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm has a market cap of $85.03 billion, a P/E ratio of 15.72, a P/E/G ratio of 1.10 and a beta of 1.48. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company's revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $5.36 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.